Novozymes buys enzyme supplier

02/5/2013 | Bloomberg

Novozymes expects to increase sales and efficiency through the purchase of Bio-Products, a unit of Iogen that was auctioned off. "We get a number of products that complement our existing product portfolio and welcome a talented group of employees who are very good at developing and producing industrial enzymes," Novozyme executive Andrew Fordyce said.

View Full Article in:

Bloomberg

Published in Briefs: